Answers are grounded in this paper and cite their sources.
Introduction Fecal calprotectin (FC) results may be unavailable during assessment of inflammatory or ulcerative intestinal lesions. We assessed FC documentation and developed a diagnostic prediction model using endoscopic features and blood-derived inflammatory indices for ulcerative colitis (UC). Methods We retrospectively included 655 patients from four centers. Four prespecified logistic models were compared in complete cases ( N = 455; 103 UC cases). Performance included discrimination, Brier score, calibration, and decision curves. Internal validation used 1,000 bootstrap resamples; transportability was assessed by leave-one-center-out cross-validation. LASSO-based analyses were exploratory; multiple imputation also assessed the robustness of the four primary models. Results FC was documented in 6 patients (0.9%). A model combining mucosal granularity, mucosal edema, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index had an apparent area under the receiver operating characteristic curve (AUC) of 0.739 (95% CI 0.684–0.795) and an optimism-corrected AUC of 0.733. It exceeded the blood-derived index model (AUC=0.594, P < 0.001) and simplified endoscopic model (AUC = 0.711, P = 0.024), but did not differ significantly from the three-item endoscopic model comprising vascular pattern abnormality, bleeding, and erosions/ulcers (AUC = 0.758, P = 0.521). At a cutoff of 0.155, Negative predictive value was 0.901. LASSO selected vascular pattern abnormality, bleeding, and mucosal granularity (optimism-corrected AUC = 0.746). Discussion The combined model showed moderate discrimination, with modest incremental value from blood-derived indices.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: